ACRS vs STT · rev $3.6M vs P/E 17, rev $7.84B
Aclaris Therapeutics Inc (ACRS) versus State Street Corp (STT) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
State Street Corp (STT) is a asset management company listed on US.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported STT revenue for 2026-06-30 was $7.84B. Net income was $1.85B. STT currently screens at market cap $45.02B and trailing P/E 16.5.
ACRS currently screens at market cap $615.9M. STT currently screens at market cap $45.02B and trailing P/E 16.5.
Not investment advice. Open the ACRS and STT stock pages for the full models.
Not investment advice.